Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | LSS | P48449 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438756 | 0.94 | IDO1 (0.52) | L3MBTL1TDP1IDO1ALOX5MEN1 | |
| SCHEMBL11917760 | 0.91 | MEN1 (0.49) | L3MBTL1IDO1ALOX5MEN1KMT2A | |
| SCHEMBL144596 | 0.86 | MAPT (0.42) | L3MBTL1TDP1IDO1 | |
| SCHEMBL101220 | 0.84 | L3MBTL1 (0.53) | L3MBTL1TDP1HRH3 | |
| SCHEMBL21218213 | 0.82 | TAAR1 (0.38) | L3MBTL1TDP1IDO1 | |
| SCHEMBL198056 | 0.82 | IDO1 (0.58) | L3MBTL1TDP1IDO1MAOAMEN1 | |
| Bromide SCHEMBL22729363 | 0.81 | THRB (0.36) | L3MBTL1TDP1MEN1KMT2A | |
| SCHEMBL16314162 | 0.80 | TDP1 (0.50) | L3MBTL1TDP1IDO1FFAR1SIGMAR1 | |
| SCHEMBL7449055 | 0.80 | TDP1 (0.61) | L3MBTL1TDP1IDO1MAOAMEN1 | |
| SCHEMBL7448881 | 0.80 | TDP1 (0.61) | L3MBTL1TDP1IDO1MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11761121-B2 | Method for producing polyacetal fiber | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11441242-B2 | Method for manufacturing polyacetal fiber | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-09-13 | — | — | US | disclosed |
| EP-4050134-A1 | POLYACETAL FIBERS, METHOD FOR PRODUCING SAME AND MATERIAL FOR DRAWING | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-08-31 | — | — | EP | disclosed |
| CN-113557327-B | Polyacetal fiber, method for producing same, and material for drawing | 三菱瓦斯化学株式会社 | 2022-06-28 | — | — | CN | disclosed |
| CN-110892100-B | Method for producing polyacetal fiber | 三菱瓦斯化学株式会社 | 2022-05-13 | — | — | CN | disclosed |
| CN-110869547-B | Method for producing polyacetal fiber | 三菱瓦斯化学株式会社 | 2022-04-15 | — | — | CN | disclosed |
| US-20210388534-A1 | POLYACETAL FIBERS, METHOD FOR PRODUCING SAME AND MATERIAL FOR DRAWING | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2021-12-16 | — | — | US | disclosed |
| CN-113557327-A | Polyacetal fiber, method for producing same, and material for drawing | 三菱瓦斯化学株式会社 | 2021-10-26 | — | — | CN | disclosed |
| US-11084842-B2 | Glucopyranosyl derivative and use thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2021-08-10 | — | — | US | disclosed |
| EP-2902535-B1 | MULTIFILAMENT OF A POLYACETAL STRETCHED FIBER | MITSUBISHI GAS CHEMICAL CO (JP) | 2021-05-12 | — | — | EP | disclosed |
| US-20120101075-A2 | Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor | LABORATORIOS ALMIRALL, S.A. (ES) | 2012-04-26 | — | — | US | disclosed |
| EP-1885684-B9 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA-2 ADRENERGIC RECEPTOR | ALMIRALL SA (ES) | 2012-04-25 | — | — | EP | disclosed |
| US-20110251165-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR | ALMIRALL, S.A. | 2011-10-13 | — | — | US | disclosed |
| US-20110251166-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR | PUIG DURAN CARLOS | 2011-10-13 | — | — | US | disclosed |
| EP-1885684-B1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA-2 ADRENERGIC RECEPTOR | ALMIRALL SA (ES) | 2011-07-13 | — | — | EP | disclosed |
| US-7964615-B2 | Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptor | ALMIRALL, S.A. (ES) | 2011-06-21 | — | — | US | disclosed |
| EP-2263998-A1 | Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor | Almirall S.A. (ES) | 2010-12-22 | — | — | EP | disclosed |
| US-20090042933-A1 | Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor | ALMIRALL, S.A. (ES) | 2009-02-12 | — | — | US | disclosed |
| EP-1885684-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA-2 ADRENERGIC RECEPTOR | Laboratorios Almirall, S.A. (ES) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006122788-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR | LABORATORIOS ALMIRALL, S.A. (ES) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251166-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR | ADRB2, ADRA2C, ADRB1 | L3MBTL1 3136/4885TDP1 4690/4885IDO1 1397/4885 |
| US-20110251165-A1 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR | ADRB2, ADRA2C, ADRB3 | L3MBTL1 3439/4885TDP1 4721/4885IDO1 1429/4885 |
| US-20090042933-A1 | Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor | ADRB2, ADRA2C, ADRB1 | L3MBTL1 3262/4885TDP1 4691/4885IDO1 2032/4885 |
| US-11084842-B2 | Glucopyranosyl derivative and use thereof | SLC5A1, SLC5A2, UGGT1 | L3MBTL1 4035/4885TDP1 4284/4885IDO1 3419/4885 |
| US-20120101075-A2 | Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor | ADRB2, ADRB1, ADRA2C | L3MBTL1 4464/4885TDP1 2848/4885IDO1 2610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.